Staphylococcus aureus enterotoxins: A key in airway disease?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 6, 2002, Pages 480-487

  Bachert, C ^a   Gevaert, P ^a   Van Cauwenberge, P ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN E; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS SUPERANTIGEN; SUPERANTIGEN; UNCLASSIFIED DRUG; ENTEROTOXIN;

ASTHMA; BACTERIAL COLONIZATION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INCIDENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RHINITIS; SINUSITIS; STAPHYLOCOCCUS AUREUS; IMMUNOLOGY;

ENTEROTOXINS; HUMAN; RESPIRATORY TRACT DISEASES; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; HUMANS;

EID: 0036614953     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.02156.x     Document Type: Review

References (80)

1. Infectious diseases, tropical medicine and sexually transmitted diseases
2. Staphylococcal enetrotoxins
3. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus
4. Superantigens
5. Characterization and distribution of a new enterotoxin-related superantigen produced by Staphylococcus aureus
6. Biochemical and biological properties of Staphylococcal enterotoxin K
7. The spectral and thermodynamic properties of staphylococcal enterotoxin A, E, and variants suggests that structural modifications are important to control their function
8. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen
9. Vbeta-dependent stimulation of bovine and human T-cells by host-specific staphylococcal enterotoxins
10. Antagonistic effects of the staphylococcal enterotoxin mutant, SEA (F47A/D227A), on psoriasis in the SCID-hu xenogenic transplantation model
11. Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDD
12. Modulatory effects of staphylococcal superantigen TSST-1 on IgE synthesis in atopic dermatitis
13. A toxic shock syndrome toxin x 1 mutant that defines a functional site critical for T-cell activation
14. Sequence of the toxic shock syndrome toxin gene (tstH) borne by strains of Staphylococcus aureus isolated from patients with Kawasaki syndrome
15. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome
16. Unique superantigen activity of staphylococcal exfoliative toxins
17. B-cell superantigens: Definition and potential impact on the immune response
18. Adoptive transfer of a superantigen-induced hole in the repertoire of natural IgM-secreting cells
19. Structural evidence for the evolution of pyrogenic toxin superantigens
20. The structural basis of T-cell activation by superantigens
21. Localization of a site on bacterial superantigens that determines T-cell receptor beta chain specificity
22. Major histocompatibility complex I molecule serves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T-cells
23. Bacterial infections and atopic dermatitis
24. Different superantigens interact with distinct sites in the Vbeta domain of a single T-cell receptor
25. Superantigens and their association with dermatological inflammatory diseases: Facts and hypotheses
26. Cutting edge: Trimolecular interaction of TCR with MHC class II and bacterial superantigen shows a similar affinity to MHC, peptide ligands
27. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin x 1 to T-cells
28. Immune response to staphylococcal superantigens
29. The role of IL-4 in the staphylococcal enterotoxin B-triggered immune response: Increased susceptibility to shock and deletion of CD8Vbeta8 + T-cells in IL-4 knockout mice
30. Cytokines and T-cell responses in superantigen-related glomerulonephritis following methicillin-resistant Staphylococcus aureus infection
31. Cell adhesion molecules are co-receptors for staphylococcal enterotoxin B-induced T-cell activation and cytokine production
32. Synovial cells are potent antigen-presenting cells for superantigens
33. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide co-stimulation for superantigen-induced T-lymphocyte proliferation in the absence of a specific presenting molecule
34. IL-10 directly acts on T-cells by specifically altering the CD28 costimulation pathway
35. B-cell superantigens: Potential modifiers of normal human B-cell repertoire
36. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity
37. Staphylococcal enterotoxin A induces survival of VH3-expressing human B-cells by binding to the VH region with low affinity
38. Mechanisms of protein A superantigen-induced signal transduction for proliferation of mouse B-cell
39. Staphylococcal enterotoxin D functions as a human B-cell superantigen by rescuing VH4-expressing B-cells from apoptosis
40. The superantigen toxic shock syndrome toxin x 1 induces CD40 ligand expression and modulates IgE isotype switching
41. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin x 1 in peripheral blood mononuclear cells from patients with atopic dermatitis
42. T-helper cell dependent microbial superantigen-mediated B-cell activation in vivo
43. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen
44. Human eosinophils as antigen-presenting cells relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation
45. Pro-inflammatory effects of staphylococcal exotoxins on eosinophils: Inhibition of apoptosis and modulation of cell surface antigens
46. Inhibition of T-cell superantigen following treatment with the kappa-opioid agonist U50,488H
47. Monocyte-derived macrophages prime peripheral T cells to undergo apoptosis by cell-to-cell contact viaICAM-1/LFA-1 dependent mechanism
48. Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA)
49. Cross-linking staphylococcal enterotoxin A bound to major histocompatibility complex class I is required for TNF-alpha secretion
50. Superantigens augment antigen-specific Th1 responses by inducing IL-12 production in macrophages
51. Induction of interleukin 12/p40 by superantigens in macrophages is mediated by activation of nuclear factor-kappaB
52. 2 fragment of human IgG
53. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E
54. Staphylococcal enterotoxin B inhibits the production of interleukin-4 in a human mast-cell line HMC-1
55. MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation
56. Modulation of cytokine production from an epiocular corneal cell culture model in response to Staphylococcus aureus superantigen
57. Nitric oxide participates in the recovery of normal jejunal epithelial ion transport following exposure to the superantigen, Staphylococcus aureus enterotoxin B
58. Epithelial ion transport and barrier abnormalities of immune cells are inhibited by interleukin-10 but not interleukin-4
59. Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: Inhibition of increased permeability but not diminished secretory responses by TGF-beta2
60. A revised nomenclature for allergy
61. Bacterial allergy in allergic rhinitis and bronchial asthma
62. Specific serum IgE antibodies to bacterial antigens in allergic lung disease
63. Anti-Staphylococcus aureus, anti-Streptococcus pneumoniae and anti-Morexella catarrhalis specific IgE in asthmatic children
64. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation
65. Influenza A virus enhances Stapyhlococcus aureus-induced basophil histamine release in normal individuals and patients with intrinsic asthma
66. Bacteria and endotoxin enhance basophil histamine release and potentiation is abolished by carbohydrates
67. Potentiation of histamine release against inhalant allergens (Dermatophagoides pteronyssinus) with bacterial antigens in bronchial asthma
68. Increased T-cell receptor vbeta8+ T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: A potential role for microbial superantigens
69. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens
70. Superantigens and cystic fibrosis: Resistance of presenting cells to dexamethasone
71. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness - A model for non-allergic asthma
72. Various immunological phenotypes are associated with increased airway responsiveness
73. Value of antral puncture in the intensive care patient with fever of unknown origin
74. Microbiology of the middle meatus: A comparison between normal adults and children
75. What is the bacteriology of chronic sinusitis in adults?
76. Staphylococcus aureus nasal carriage in patients with rhinosinusitis
77. Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis
78. Clinical experiences with fusidic acid in cystic fibrosis patients
79. Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis
80. Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B